{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T08:37:48Z","timestamp":1720168668146},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jns.2017.09.036","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T02:15:54Z","timestamp":1506564954000},"page":"84-86","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A retrospective study of acetylcholine receptor antibody positive ocular myasthenia in the West of Scotland"],"prefix":"10.1016","volume":"382","author":[{"given":"Maria E.","family":"Farrugia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.jns.2017.09.036_bb0005","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2017.09.036_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archopht.1965.00970040219016","article-title":"Myasthenia gravis: a review of the disease and a description of lid twitch as a characteristic sign","volume":"74","author":"Cogan","year":"1965","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jns.2017.09.036_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/CND.0b013e31821c5634","article-title":"Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response","volume":"13","author":"Mittal","year":"2011","journal-title":"J. Clin. Neuromuscul. Dis."},{"issue":"3","key":"10.1016\/j.jns.2017.09.036_bb0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/WNO.0b013e3182536558","article-title":"Safety of prednisone for ocular myasthenia gravis","volume":"32","author":"Bruce","year":"2012","journal-title":"J. Neuroophthalmol."},{"issue":"8","key":"10.1016\/j.jns.2017.09.036_bb0025","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00415-009-5120-8","article-title":"Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up","volume":"256","author":"Kupersmith","year":"2009","journal-title":"J. Neurol."},{"issue":"24","key":"10.1016\/j.jns.2017.09.036_bb0030","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1212\/01.wnl.0000263481.14289.90","article-title":"Quality Standards Subcommittee of the American Academy of Neurology. Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"68","author":"Benatar","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2017.09.036_bb0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.24769","article-title":"Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): a randomized, controlled trial","volume":"53","author":"Benatar","year":"2016","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jns.2017.09.036_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11940-011-0151-8","article-title":"Treatment of ocular myasthenia gravis","volume":"14","author":"Haines","year":"2012","journal-title":"Curr. Treat. Options Neurol."},{"issue":"3","key":"10.1016\/j.jns.2017.09.036_bb0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/practneurol-2015-001126","article-title":"Myasthenia gravis: Association of British Neurologists' management guidelines","volume":"15","author":"Sussman","year":"2015","journal-title":"Pract. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2017.09.036_bb0050","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ene.12359","article-title":"EFNS\/ENS Guidelines for the treatment of ocular myasthenia","volume":"21","author":"Kerty","year":"2014","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2017.09.036_bb0055","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jns.2017.09.036_bb0060","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.09.036_bb0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/IJGM.S129075","article-title":"Factors predicting the outcomes of elderly hospitalized myasthenia gravis patients: a national database study","volume":"10","author":"Tiamkao","year":"2017","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.jns.2017.09.036_bb0070","first-page":"730","article-title":"Ocular divergence mechanisms","volume":"68","author":"Jampolsky","year":"1970","journal-title":"Trans. Am. Ophthalmol. Soc."},{"issue":"Pt 4","key":"10.1016\/j.jns.2017.09.036_bb0075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/eye.1993.123","article-title":"Diagrammatic representation of strabismus","volume":"7","author":"Vivian","year":"1993","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jns.2017.09.036_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08820538.2015.1131835","article-title":"Ptosis repair in ocular myasthenia gravis","volume":"18","author":"Belliveau","year":"2016","journal-title":"Semin. Ophthalmol."},{"issue":"12","key":"10.1016\/j.jns.2017.09.036_bb0085","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1167\/iovs.10-5937","article-title":"Myosin heavy chain expression in mouse extraocular muscle: more complex than expected","volume":"51","author":"Zhou","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"21","key":"10.1016\/j.jns.2017.09.036_bb0090","doi-asserted-by":"crossref","first-page":"12062","DOI":"10.1073\/pnas.211257298","article-title":"Extraocular muscle is defined by a fundamentally distinct gene expression profile","volume":"98","author":"Porter","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jns.2017.09.036_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2017.09.036_bb0100","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/mus.25397","article-title":"Early fast-acting treatment strategy against generalized myasthenia gravis","volume":"55","author":"Utsugisawa","year":"2017","journal-title":"Muscle Nerve"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17343411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17343411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T03:33:53Z","timestamp":1535340833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17343411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":20,"alternative-id":["S0022510X17343411"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.09.036","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective study of acetylcholine receptor antibody positive ocular myasthenia in the West of Scotland","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}